ANTIMICROBIAL RESISTANCE (AMR)

2018 AGENDA FOR AMR SPECIAL SESSION

 

DESCRIPTION

The focus of this 3-day workshop is on understanding the complex causes underlying the emergence and spread of AMR, and on practical approaches to tackle antibiotic misuse in different settings.

 

Course Directors

Makeda Semret, MSc, MD, FRCPC

Lead, Antimicrobial Stewardship Program, McGill University Health Centre

Director, Training Program in Infectious Diseases and Medical Microbiology, McGill University

 
Erika Vlieghe MD
Head of the department of General Internal Medicine, Infectious diseases and Tropical Medicine, University Hospital Antwerp
Professor of infectious diseases, University of Antwerp

 

Course Faculty

Haileyesus Getahun Gebre, MD PhD MPH – AMR secretariat, WHO, Geneva
Peter J. Dailey, PhD, MPH – University of California, Berkeley
Jorg Janne Vehreschild, MD – University of Cologne
Christian Lavallée, MD – Université de Montréal
Yoshiko Nakamachi, RN, BScN, BA, PMP – University Health Network, Toronto

Cédric Yansouni, MD, FRCPC, DTM&H – McGill University

Louis-Patrick Haraoui, MD MSc – Université de Sherbrooke

Michael Libman, MD FRCP – McGill University
 
Faculty members are still being confirmed and there may be changes to the above list
 

Content

Antimicrobial resistance (AMR) is now one the biggest threats facing modern medicine. Initially described mostly in association with hospital-associated infections in high-income countries, the highest rates of AMR are now reported from low and middle-income countries (LMIC) around the world. The causes underlying the global rise in AMR are complex, but central to this crisis is overconsumption of antibiotics.

 

This 3-day workshop will focus on understanding the complex causes underlying the emergence and spread of AMR, and on approaches to tackle antibiotic misuse in different settings. The workshop format is a mix of plenary talks and panel discussions, with opportunities to interact with participants who work across the spectrum of the antimicrobial resistance space in different countries.
 
Clinicians, researchers, implementers, and health educators from both high-income and LMIC will share questions, successes, and lessons learned to advance the field of AMR.

 

NOTE: Global Health Diagnostics and the Antimicrobial Resistance course will be taught together on Wednesday, June 12th.

 

TARGET AUDIENCE

This course appeals to a wide range of participants including:

  • Clinicians, pharmacists, technologists, researchers and students studying infectious diseases, tropical medicine, or global health
  • Policy makers and public health agency officials
  • Product developers and funders
  • Community advocacy groups working in global health

 

ENROLMENT

Maximum of 100 participants.